Pilot clinical study into iPS cell therapy for eye disease starts in Japan

RIKEN is pleased to announce the launch of a pilot study to assess the safety and feasibility of the transplantation of autologous induced pluripotent stem cell -derived retinal pigment epithelium cell sheets in patients with exudative age-related macular degeneration This study, led by Masayo Takahashi M.D., Ph.

http://www.innovations-report.com/html/reports/studies/pilot_clinical_study_ips_cell_therapy_eye_disease_217746.html